|
GXYLT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.07559999995566E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.50219999994761E-06 |
| Normal-vs-Stage2 |
1.913400E-01 |
| Normal-vs-Stage3 |
5.276000E-03 |
| Normal-vs-Stage4 |
1.601050E-03 |
| Stage1-vs-Stage2 |
1.705980E-01 |
| Stage1-vs-Stage3 |
2.945200E-01 |
| Stage1-vs-Stage4 |
8.250800E-01 |
| Stage2-vs-Stage3 |
5.488600E-01 |
| Stage2-vs-Stage4 |
1.927040E-01 |
| Stage3-vs-Stage4 |
3.218600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.20439999995448E-06 |
| Normal-vs-AfricanAmerican |
3.462400E-03 |
| Normal-vs-Asian |
3.722400E-02 |
| Caucasian-vs-AfricanAmerican |
2.367600E-01 |
| Caucasian-vs-Asian |
1.530750E-01 |
| AfricanAmerican-vs-Asian |
7.357700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.859590E-02 |
| Normal-vs-Female |
2.29019999964386E-07 |
| Male-vs-Female |
7.842500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.59939999999636E-06 |
| Normal-vs-Age(41-60Yrs) |
4.635300E-04 |
| Normal-vs-Age(61-80Yrs) |
4.741400E-03 |
| Normal-vs-Age(81-100Yrs) |
9.154600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.534810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.571000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.756400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.718800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.320600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.455600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.633200E-01 |
| Classical-VS-Follicular |
5.124400E-03 |
| Classical-VS-Other |
2.307800E-01 |
| Classical-VS-Normal |
1.85640000038845E-08 |
| Tall-VS-Follicular |
3.958000E-01 |
| Tall-VS-Other |
4.498600E-01 |
| Tall-VS-Normal |
4.875600E-02 |
| Follicular-VS-Other |
7.955600E-01 |
| Follicular-VS-Normal |
1.914970E-01 |
| Other-VS-Normal |
8.568000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.238700E-04 |
| Normal-vs-N1 |
1.889550E-02 |
| N0-vs-N1 |
7.119200E-01 |
|
|
